Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.910
-0.050 (-2.55%)
Nov 20, 2024, 4:00 PM EST - Market closed
Cellectis Market Cap
Cellectis has a market cap or net worth of $182.72 million as of November 21, 2024. Its market cap has increased by 19.11% in one year.
Market Cap
182.72M
Enterprise Value
117.46M
1-Year Change
19.11%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $182.72M, a decrease of -86.40%. That is a compound annual growth rate of -18.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 196.20M | 14.60% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InfuSystem Holdings | 191.80M |
| Profound Medical | 191.67M |
| ADC Therapeutics | 191.45M |
| Zura Bio | 189.35M |
| Sight Sciences | 189.31M |
| Compass Therapeutics | 188.50M |
| BrainsWay | 184.55M |
| Nektar Therapeutics | 184.46M |